You Position: Home > Paper
Advances in the study of A2B adenosine receptor antagonists
( views:169, downloads:31 )
- Author:
- No author available
- Journal Title:
- ACTA PHARMACEUTICA SINICA
- Issue:
- 3
- DOI:
- 10.3321/j.issn:0513-4870.2008.03.003
- Key Word:
- 腺苷受体;选择性拮抗剂;构效关系
Abstract： A2B腺苷受体参与激活肥大细胞和炎症细胞的活性功能,选择性A2B腺苷受体作为潜在的药物靶点正逐渐成为一个充满希望的研究热点.本文对近年来国内外有关A2B腺苷受体拮抗剂的文献资料进行了分析和归纳.首先介绍了选择性A2B腺苷受体拮抗剂药理学作用和开发意义;然后对选择性A2B腺苷受体拮抗剂的开发现状、构效关系及拮抗剂与受体相互作用情况作了深入讨论;最后,对选择性A2B腺苷受体拮抗剂研发前景进行了展望.
- [1]Ulrike Reith,Christa E. Muller,Ulrike Schobert,etc.1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A_(2B)-Selective Adenosine Receptor Antagonists[J].2002,45(7).
- [2]Igor I.Basking,Andrei A.Ivanov,Pier G.Baraldi,etc.Molecular Modeling and Molecular Dynamics Simulation of the Human A_(2B)Adenosine Receptor.The Study of the Possible Binding Modes of the A_(2B)Receptor Antagonists[J].2005,48(22).
- [3]Olah ME,Stiles GL.The role of receptor structure in determining adenosine receptor activity.[J].2000,85(2).
- [4]Naser Abdel Zaid,Pier Giovanni Baraldi,Francesca Fruttarolo,etc.Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A_(2B) Adenosine Receptor Antagonists[J].2004,47(6).
- [5]Kenneth A. Jacobson,Ad P. Ijzerman and,Joel Linden.1,3-dialkylxanthine derivatives having high potency as antagonists at human A<sub>2B</sub> adenosine receptors[J].1999,47(1).
- [6]Wang SQ,Gao SF,Wei J,etc.3D-pharmacophore models for selective A(2A) and A(2B) adenosine receptor antagonists[J].2007,47(2).
- [7]Rosaria, Volpini,Stefano, Costanzi,Sauro, Vittori,etc.Medicinal chemistry and pharmacology of A2B adenosine receptors.[J].2003,3(4).
- [8]Elzein E,Varkhedkar V,Zablocki J,etc.Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: High affinity and selective A(2B) adenosine receptor antagonists[J].2006,49(12).
- [9]I, Feoktistov,I, Biaggioni.Adenosine A2B receptors.[J].1997,49.
- [10]Lefkowitz RJ.Historical review: A brief history and personal retrospective of seven-transmembrane receptors.[J].2004,25(8).
- [11]Gimbel A,Leung K,Zeng D,etc.The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma.[J].2005,15(3).
- [12]Yong-Chul Kim,Yishai Karton,Xiao-duo Ji,etc.Acyl-hydrazide derivatives of a xanthine carboxylic congener (XCC) as selective antagonists at human A<sub>2B</sub> adenosine receptors[J].1999,47(4).
- [13]Tranter P,Tweed M,Tuffnell AR,etc.A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential.[J].2005,15(12).
- [14]Katia Varani,Pier Giovanni Baraldi,Pier Andrea Borea,etc.Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as Adenosine Receptor Antagonists. Influence of the N5 Substituent on the Affinity at the Human A_3 and A_(2B) Adenosine Receptor Subtypes: A Molecular Modeling Investigation[J].2003,46(20).
- [15]Muller CE,Bertarelli DCG,Hayallah AM,etc.A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A(2B) receptor antagonists[J].2006,49(14).
- [16]Sotelo E,Nicolotti O,Stefanachi A,etc.8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A(2B).[J].2004,39(10).
- [17]Cristina Esteve,Nuria B.Centeno,Maria Isabel Loza,etc.Design, Synthesis, and Structure-Activity Relationships of 1-,3-,8-, and 9-Substituted-9-deazaxanthines at the Human A_(2B) Adenosine Receptor[J].2006,49(1).
- [18]Song JP,McKibben B,Castelhano AL,etc.3H)OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors.[J].2004,68(2).
- [19]Melman N,Linden J,Ji X,etc.Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.[J].2000,43(6).
- [20]Kim SA,Linden J,Ji X,etc.Quinazolines as adenosine receptor antagonists: SAR and selectivity for A(2B) receptors.[J].2003,11(1).